Endocardial Myxomatous Change in Harlan Sprague-Dawley Rats (Hsd:S—D) and CD-1 Mice: Its Microscopic Resemblance to Drug-Induced Valvulopathy in Humans

Abstract

A full assessment of all heart valves in rats and mice is often impractical and is usually not performed in routine toxicity studies, largely due to an inevitable inconsistency of histological sampling. The majority of reported heart valve changes involve the examination of a single, semirandom section through the heart and the valvulopathy occurring with age or induced by xenobiotics may have been generally underestimated in mice and rats. Here we describe the incidence and microscopic features of endocardial myxomatous change (EMC) in Hsd:S—D rats and CD-1 mice. EMC was common and widespread in both CD-1 mice and Hsd:S—D rats (188 of 220 rats and 96 of 215 mice were affected by EMC). Microscopically, EMC consisted of focal or segmental thickening of valves, primarily due to the presence of fibromyxoid tissue in the subendocardium. Occasionally, fibrin or thrombi deposits and collection of neutrophils or mononuclear cells were observed. These microscopic features were similar to those seen in valvular disease in humans induced by fenfluramine-phentermine (fen-phen), ergot alkaloids (ergotamine, methysergide), and carcinoid syndrome. The mitral valve in rats and pulmonary valve in mice were most frequently affected. An association between murine progressive cardiomyopathy (MPC) and EMC was noted only in rats, suggesting that there may be a possible relationship between MPC and EMC. However, additional research is needed to confirm a relationship between EMC and MPC in rats and/or mice.

Keywords

Endocardial myxomatous change age-related Sprague-Dawley rats CD-1 mice valvular disease atrial thrombosis murine progressive cardiomyopathy.

References

Angrist A. , Oka M. , Nakao K. , Marquiss J. (1960). Studies on experimental endocarditis: 1. Production of valvular lesions by mechanisms not involving infection or sensitivity factors . Am J Pathol 36: 181—199.

Boorman GA , Zurcher C. , Hollander CF , Rijswik ZH , Ferrans VJ (1973). Naturally occurring endocardial disease in the rat. Arch Pathol 96: 39— 45.

Bratter J. , Gessner IH , Rowland NE (1999). Effects of prenatal coadministration of phentermine and dexfenfluramine in rats. Eur J Pharmacol 369(3): R1—3.

Carabello BA , Crawford FA (1997). Valvular heart disease . NEJM 337: 32—41.

Chesebro JH , Lam JY , Badimon L. , Fuster V. (1987). Restenosis after arterial angioplasty: A hemorrheologic response to injury. Am J Cardiol 60: 10—16.

Clower BR (1968). Relation of levels of dietary fat to atrial thrombosis in RF mice. J Atheroscler Res 8: 885—890.

Coleman GL , Barthold SW , Osbaldiston GW , Foster SJ , Jones AM (1977). Pathological changes during aging in barrier reared Fischer 344 male rats. J Gerontol 32: 258—278.

Connolly HM , Crary JL , McGoon MD , Hensrud DD , Edwards BS , Edwards WD , SchaffHV (1997). Valvular heart disease associated with fenfluraminephentermine . NEJM 337: 581—588.

Douglas SA , Ohlstein EH (1993). Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 22: S371—S373.

10.

Faccini JM , Abbott DP , Paulus GJJ (1990). Cardiovascular system. In: Mouse Histopathology. Elsevier Science Publishing Company, New York, pp 64—71.

11.

Fry R. , Hamilton K. , Lisco H. (1965). Thrombi in the left atrium of the heart of mice . Arch Pathol 80: 308—313.

12.

Fujihara S. , Yamamoto T. , Matsumoto M. , Yoshizawa K. , Oishi Y. , Fujii T. , Noguchi H. , Mori H. (1993). The high incidence of atrial thrombosis in mice given doxorubicin. Toxicol Pathol 21: 362—368.

13.

Goodman DG , Ward JM , Squire RA , Chu KC , Linhart MS (1979). Neoplastic and non-neoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol 48: 237—248.

14.

Graham DJ , Green L. (1997). Further cases of valvular heart disease associated with fenfluramine-phentermine [letter]. NEJM 337: 635.

15.

Greaves P. (2000). Cardiovascular system. In: Histopathology of Preclinical Toxicity Studies, Interpretation and Relevance in Drug Safety Evaluation. Elsevier, Amsterdam , Netherlands, pp 255—311.

16.

Greaves P. , Faccini JM (1984). Cardiovascular system. In: Rat Histopathology. Elsevier, Amsterdam , pp 74—85.

17.

HauckAJ , Edwards WD , Danielson GK , Mullany CJ , Bresnahan DR (1990). Mitral and aortic valve disease associated with ergotamine therapy for migraine. Arch Pathol Lab Med 114: 62—64.

18.

Hershel J. (2000). Heart valve disorders and appetite-suppressant drugs (Editorial). JAMA 283: 1738—1740.

19.

Khan MA , Herzog CA , St. Peter JV , Hartley GG , Madlon-Kay R. , Dick CD , Asinger RW , Vessey JT (1998). The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. NEJM 339: 713—718.

20.

Kroes R. , Garbis-Berkvens JM , deVries T. , van Nesselrooy JHJ (1981). Histopathological profile of a Wistar rat stock including a survey of the literature. J Gerontol 36: 259—279.

21.

Kurz X. , Van Ermen A. (1997). Valvular heart disease associated with fenfluramine-phentermine . NEJM 337: 1772—1773.

22.

Lewis, DJ (1980). Subendocardial fibrosis in the rat: A light and electron microscopic study. J Comp Pathol 90: 577—583.

23.

Lewis, DJ (1992). Nonneoplastic lesions in the cardiovascular system In: Pathobiology of the Aging Rat, Mohr U , Dungworth DL , Capen CC (eds). ILSI Press, Washington DC, pp 301—309.

24.

MacKenzie WF , Alison R. (1990). Heart. In: Pathology of the Fischer Rat, Boorman GA , Eustis SL , Elwell MR , Montgomery CA , MacKenzie WF (eds). Academic Press Inc, San Diego, CA, pp 461—472.

25.

Maeda H. , Gleiser CA , Masoro EJ , Murato I. , McMahan CA , Yu BP (1985). Nutritional influences on aging Fischer 344 rats: II. Pathology. J Gerontol 40: 671—688.

26.

Maita K. , Hirano M. , Harada T. , Mitsumori K. , Yoshida A. , Takahashi K. , Nakashima N. , Kitazawa T. , Enomoto A. , Inui K. ( 1988). Mortality, major cause of moribundity and spontaneous tumors in CD-1 mice. Toxicol Pathol 16: 340—349.

27.

Mow T. , Pedersen HD (1999). Increased endothelin-receptor density in myxomatous canine mitral valve leaflets. J Cardiovasc Pharmacol 34: 254— 260.

28.

Pedersen HD , Haggstrom J. (2000). Mitral valve prolapse in the dog: A model of mitral valve prolapse in man. Cardiovasc Res 47: 234—243.

29.

Pettersen JC , Morrissey RL , Saunders DR , Pavkov KL , Luempert III LG , Turnier JC , Matheson DW , Schwartz, DR (1996). A 2-year comparison study of Crl:CD BR and Hsd:Sprague-Dawley SD rats . Fundam Appl Toxicol 33: 196—211.

30.

Pellikka PA , Tajik AJ , Khandheria BK , Seward JB , Callahan JA , Pitot HC , Kvols LK (1993). Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients . Circulation 87: 1188—1196.

31.

Rasmussen S. , Corya BC , Glassman RD (1997). Valvular heart disease associated with fenfluramine-phentermine [letter]. NEJM 337: 1773.

32.

Redfield MM , Nicholson WJ , Edwards WD , Tajik AJ (1992). Valve disease associated with ergot alkaloid use: Echocardiographic and pathologic correlations. Ann Intern Med 117: 50—52.

33.

Robiolio PA , Rigolin VH , Wilson JS , Harrison JK , Sanders LL , Bashore TM , Feldman JM (1995). Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92: 790—795.

34.

Roberts WC , Kehoe JA , Carpenter DF , Golden A. (1968). Cardiac valvular lesions in rheumatoid arthritis . Arch Intern Med 122: 141—146.

35.

Ruben Z. , Arceo RJ , Bishop SP , Elwell MR , Kerns WD , Mesfin GM , Sandusky GE, Van Vleet (2000). Non-proliferative lesions of the heart and vasculature in rats. CV-1. In: Guides for Toxicologic Pathology STP/ARP /AFIP, Washington DC, pp 1—10.

36.

Schoen FJ (1999). The heart. In: Pathologic Basis of Disease, Cotran RS , Kumar V , Collins T (eds). W.B. Saunders Company, Philadelphia , pp 543— 599.

37.

SoRelle R. (1999). Diet drug maker agrees to $3.75 billion settlement [news]. Circulation 100: e133—134.

38.

Steffee CH , Singh HK , Chitwood WR (1999). Histologic changes in three explanted native cardiac valves following use of fenfluramines. Cardiovasc Pathol 8: 245—253.

39.

Trachtenberg JD , Sun S. , Choi ET , Callow AD , Ryan US (1993). Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol 22: S355—S359.

40.

Ward JM , Goodman DG , Squire RA , Chu KC , Linhart MS (1979). Neoplastic and non-neoplastic lesions in aging (C57BL/6N) X (C3H/HeN) F1 (B6C3F1) mice. J Natl Cancer Inst 63: 849—854.

41.

Wicks MS , Ball CR , Williams WL (1969). Relation of types of dietary fat to cardiovascular damage in mice. Am J Anat 124: 481—490.

42.

Wong J. , Reddy SS , Klein AL (1998). Anorectic drugs and valvular heart disease: A biological and clinical perspective. Cleveland Clin J Med 65: 35—41.

43.

Wolff FW (1997). Valvular heart disease associated with fenfluraminephentermine [letter]. NEJM 337: 1774.